
COVID-19 vaccines have been effective in providing strong immunity within a relatively short time frame, significantly reducing both the severity of the disease and associated mortality. However, post-vaccination complications, particularly neurological disorders, have been reported. Among the more frequently documented neurological complications are acute disseminated encephalomyelitis (ADEM), multiple sclerosis (MS), transverse myelitis (TM), optic neuritis (ON), Bell's palsy (BP), and Guillain–Barré syndrome (GBS). The precise role of COVID-19 vaccines in triggering the onset or relapse of these conditions remains uncertain. Immunological processes involving cytokines, chemokines, antibodies, and immune cells are believed to contribute to the pathogenesis of these neurological side effects. This review examines the immune responses triggered by COVID-19 vaccines and their potential role in the development of such complications. Despite reports of neurological side effects, these cases remain rare, and the overall benefits of vaccination in curbing the pandemic and preventing severe illness far exceed the risks. It is vital to sustain the progress of global vaccination efforts while continuously evaluating the risk-benefit ratio, particularly for individuals with underlying conditions. Ongoing research and surveillance are crucial for creating safer vaccines and identifying individuals who may be more susceptible to adverse reactions, ensuring broader protection against COVID-19.
Citation: Mehran Joodaki, Farhad Seif, Azadeh Afzalnia, Nikoo Emtiazi, Mona Merati Shirazi, Behnaz Ashtari, Seyed Mohamad Hosseinian, Nasrin Hosseini. COVID-19 vaccines and neurological disorders: A narrative review of immune responses and adverse reactions[J]. AIMS Neuroscience, 2025, 12(2): 222-249. doi: 10.3934/Neuroscience.2025013
[1] | Qi Cui, Ruohan Meng, Zhili Zhou, Xingming Sun, Kaiwen Zhu . An anti-forensic scheme on computer graphic images and natural images using generative adversarial networks. Mathematical Biosciences and Engineering, 2019, 16(5): 4923-4935. doi: 10.3934/mbe.2019248 |
[2] | Binjie Hou, Gang Chen . A new imbalanced data oversampling method based on Bootstrap method and Wasserstein Generative Adversarial Network. Mathematical Biosciences and Engineering, 2024, 21(3): 4309-4327. doi: 10.3934/mbe.2024190 |
[3] | Bingyu Liu, Jiani Hu, Weihong Deng . Attention distraction with gradient sharpening for multi-task adversarial attack. Mathematical Biosciences and Engineering, 2023, 20(8): 13562-13580. doi: 10.3934/mbe.2023605 |
[4] | Yalong Yang, Zhen Niu, Liangliang Su, Wenjing Xu, Yuanhang Wang . Multi-scale feature fusion for pavement crack detection based on Transformer. Mathematical Biosciences and Engineering, 2023, 20(8): 14920-14937. doi: 10.3934/mbe.2023668 |
[5] | Jiajia Jiao, Xiao Xiao, Zhiyu Li . dm-GAN: Distributed multi-latent code inversion enhanced GAN for fast and accurate breast X-ray image automatic generation. Mathematical Biosciences and Engineering, 2023, 20(11): 19485-19503. doi: 10.3934/mbe.2023863 |
[6] | Hao Wang, Guangmin Sun, Kun Zheng, Hui Li, Jie Liu, Yu Bai . Privacy protection generalization with adversarial fusion. Mathematical Biosciences and Engineering, 2022, 19(7): 7314-7336. doi: 10.3934/mbe.2022345 |
[7] | Chen Yue, Mingquan Ye, Peipei Wang, Daobin Huang, Xiaojie Lu . SRV-GAN: A generative adversarial network for segmenting retinal vessels. Mathematical Biosciences and Engineering, 2022, 19(10): 9948-9965. doi: 10.3934/mbe.2022464 |
[8] | Xing Hu, Minghui Yao, Dawei Zhang . Road crack segmentation using an attention residual U-Net with generative adversarial learning. Mathematical Biosciences and Engineering, 2021, 18(6): 9669-9684. doi: 10.3934/mbe.2021473 |
[9] | Jia Yu, Huiling Peng, Guoqiang Wang, Nianfeng Shi . A topical VAEGAN-IHMM approach for automatic story segmentation. Mathematical Biosciences and Engineering, 2024, 21(7): 6608-6630. doi: 10.3934/mbe.2024289 |
[10] | Suxiang Yu, Shuai Zhang, Bin Wang, Hua Dun, Long Xu, Xin Huang, Ermin Shi, Xinxing Feng . Generative adversarial network based data augmentation to improve cervical cell classification model. Mathematical Biosciences and Engineering, 2021, 18(2): 1740-1752. doi: 10.3934/mbe.2021090 |
COVID-19 vaccines have been effective in providing strong immunity within a relatively short time frame, significantly reducing both the severity of the disease and associated mortality. However, post-vaccination complications, particularly neurological disorders, have been reported. Among the more frequently documented neurological complications are acute disseminated encephalomyelitis (ADEM), multiple sclerosis (MS), transverse myelitis (TM), optic neuritis (ON), Bell's palsy (BP), and Guillain–Barré syndrome (GBS). The precise role of COVID-19 vaccines in triggering the onset or relapse of these conditions remains uncertain. Immunological processes involving cytokines, chemokines, antibodies, and immune cells are believed to contribute to the pathogenesis of these neurological side effects. This review examines the immune responses triggered by COVID-19 vaccines and their potential role in the development of such complications. Despite reports of neurological side effects, these cases remain rare, and the overall benefits of vaccination in curbing the pandemic and preventing severe illness far exceed the risks. It is vital to sustain the progress of global vaccination efforts while continuously evaluating the risk-benefit ratio, particularly for individuals with underlying conditions. Ongoing research and surveillance are crucial for creating safer vaccines and identifying individuals who may be more susceptible to adverse reactions, ensuring broader protection against COVID-19.
In recent years, pavement maintenance issues have received more and more attention. With the increasing mileage of global maintenance [1], and the amazingly rapid development of artificial intelligence, especially deep learning-based methods, automatic pavement distress detection methods [2,3,4,5,6], and pavement distress segmentation methods [7], have been continuously proposed to address the challenges of inspecting vast transportation infrastructure in a timely and cost-effective manner. As one of the most common pavement distresses, cracks pose risks to the structural integrity of the pavement surface if not addressed promptly through appropriate repair measures. Left unrepaired, cracks have the potential to develop into more severe issues that can further impact the service life and level of the pavement. An adequate amount of data is a prerequisite for deep learning to be feasible. Although deep learning has some advantages in the field of image vision, it relies on a massive number of samples to achieve high-precision training results. The size of the dataset must be guaranteed to ensure robustness and generalization. Compared with the modification of the model structure and optimization of the parameters, the augmentation of the data volume is usually the most expeditious avenue for enhancing performance.
In addition to acquiring more real-world pavement images through field collection, the Generative Adversarial Network (GAN) was proposed by Goodfellow et al. [8]. The feature distribution of the samples was learned and the learned features were combined to generate realistic images. Generative Adversarial Networks (GANs) are a type of deep learning model that comprises two components-a Generator and a Discriminator--which interact in a game-like manner. The objective of the Generator is to create data that closely resembles authentic examples that can deceive the Discriminator. On the other hand, the Discriminator aims to discern as accurately as possible between the real data and the synthetic data developed by the Generator. The generator and discriminator engage in a Minimax Game, where the former aims to maximize the probability of the latter misclassifying the generated samples, while the latter aims to minimize the said probability. During GAN training, certain issues may arise, such as Mode Collapse and unstable training, which require the implementation of various techniques and improved GAN structures for resolution. Since then, the GAN model has been continuously improved and many variants have been generated based on the original network structure, but there are many problems in the algorithms, such as difficulty in training the original GAN, the inability of the loss function to guide the model training process and poor diversity of the generated samples. The GAN model was improved by Arjovsky et al. [9], targeting the original JS scattering objective function through Wasserstein distance instead and casting certain improvements in the stability of training and image quality. The progressive growing GAN (PGGAN) from Karaas et al. [10] is a training method that starts with low-resolution images and continues to complicate the model by adding new network layers to gradually learn detailed features, thus achieving accelerated and stable training. Least Squares Generative Adversarial Networks (LSGANs) were generated by Mao et al. [11] to improve the quality and stability of generated images through the least squares loss function. A style-based generative adversarial network (StyleGAN) architecture was used by Karras et al. [12] to improve the quality of generated images by providing fine-grained control over the style of generated images. The application of GAN in road engineering is becoming increasingly prevalent. A hybrid generative adversarial network and variational autoencoder approach was employed by Pei et al. [13] to enhance the Deep Convolution GAN(DCGAN) model. Through iterative training and Adam optimization over multiple rounds, a vast number of virtual images nearly indistinguishable from real road crack photographs are obtained. A generative adversarial network (GAN) approach was also devised by Xu et al. [14] that leverages a small sample dataset of road cracks captured by unmanned aerial vehicles (UAVs) to train the GAN model for dataset expansion, generating additional synthetic images to augment the original training set. Mazzini [15] et al. used GAN to generate a semantic layout, and then a CNN-based texture synthesizer generated a new semantic image based on the generated semantic layout and obtained a reference real pavement disease image from the training set.
The application of deep learning for detecting defects in pavement images has been widely studied [2,3,4,5,6,7]. However, detection accuracy hinges on the quantity and quality of the dataset, typically in the tens of thousands, posing a critical prerequisite. Therefore, it is less commonly applied in practical engineering applications. The GAN network can effectively overcome this limitation. Although numerous scholars have made advancements in GANs in recent years, there are inherent limitations such as the inability to regulate the specific diseases generated and the uneven distribution of disease types within the image dataset, leading to reduced detection accuracy. As a result, the challenge of establishing high-quality training datasets quickly and cost-effectively has become a top priority. We utilize conditional GANs on a limited set of road crack data to generate road crack images and proposes a potential solution for researchers grappling with the dearth of diverse training samples given the use of deep learning in road crack and disease detection.
Generative Adversarial Networks (GANs), one of the most inventive deep learning models in modern years, have achieved tremendous achievements in the field of computer vision. By applying game theory, it generates high-quality samples in generators and discriminators. GANs are a type of deep learning model that comprises two components - a Generator and a Discriminator - which interact in a game-like manner. The objective of the Generator is to create data that closely resembles authentic examples that can deceive the Discriminator. On the other hand, the Discriminator aims to discern as accurately as possible between the real data and the synthetic data developed by the Generator. The generator and discriminator engage in a Minimax Game, where the former aims to maximize the probability of the latter misclassifying the generated samples, while the latter aims to minimize the mentioned probability. Both keep learning in the game and ideally end up generating samples that the discriminator can't distinguish between true and false. The training process is shown in Figure 1 below.
In GANs, either a fixed generator is utilized to optimize the discriminator or a fixed discriminator is employed to optimize the generator, as explained in [8]. The complete formula for the GAN model is presented below.
is the expected value of the distribution functionis the distribution of the real sample, is the distribution of the generated samples.
(1) |
Since GAN was proposed by Goodfellow in 2014, it has become one of the most popular research areas in artificial intelligence and machine learning. Until now, there has been much new research on GAN in the field of road disease detection, such as WGAN and DCGAN. In this subsection, we present representative variants of GAN.
DCGAN applies a deep convolutional neural network (CNN) as the core structure of its generator and discriminator, while the original GAN mainly employs fully connected layers. This deep convolutional structure makes DCGAN both more efficient and effective in processing image data, and the DCGAN network structure is shown in Figure 2.
Pei et al. [16] generated pavement crack images virtually by improving the Deep Convolutional Generative Adversarial Network (DCGAN) to overcome the lack of a sufficient number of samples in intelligent pavement inspection. A pavement crack detection model based on the Faster R-CNN network was built and trained with the original small dataset and the DCGAN-generated dataset. The experimental results show that the detection model trained with the Faster R-CNN model using the dataset expanded with images generated by DCGAN achieves an average accuracy of 90.32%, which is higher than that obtained by the traditional method evaluated using the same test dataset.
The original GAN minimizes the generator's loss under the near-optimal discriminator is equivalent to minimizing the JS scatter between the probability distribution of the real data and the probability distribution of the data generated by the generator, and there is a serious problem with the JS scatter: When the two distributions do not overlap, the JS scatter is zero, whereas at the beginning of the training period, the two distributions are essentially non-overlapping. Thus, if the discriminator is trained too strongly, the loss often converges to no gradient. To overcome the above issues, WGAN proposes the Wasserstein distance:
(2) |
Equation (2) represents the Wasserstein distance between two probability distributions and . Where denotes the low bound in all possible joint distributions γ, denotes all possible joint distributions of and , and is the d power of the distance between two points in Euclidean space.
The advantage of utilizing the Wasserstein distance over the JS scatter is that the JS scatter is sudden and lacks gradient where there is no overlap. However, the Wasserstein distance offers a significant gradient based on distance, even in cases where the two distributions do not overlap. This regular term is the only difference between WGAN-GP and WGAN. WGAN-GP is similar to WGAN with the addition of a regular term, GP (gradient penalty), which enforces a gradient constraint.
Xu et al. [17] employed the WGAN-GP network (The network structure is shown in Figure 3 below) to gather B-Scan image data using Ground Penetrating Radar (GPR) and generate high-quality B-Scan images via unsupervised data enhancement. Subsequently, a ResNet50 [18] model was utilized to categorize subsurface basement diseases. The results of the experiments demonstrate that the data enhancement method of WGAN-GP yielded significant improvement in the classification accuracy, with the test accuracy rising to 90.85%. The overall recall rate was 90.79% and the F1 score was 72.58%. The high-quality GPR images, produced by the combination of traditional data enhancement and WGAN-GP, have significantly bettered the classification accuracy or underground stress detection in an efficient manner and also addressed the problem of category imbalance.
In recent years, Generative Adversarial Networks (GANs) have demonstrated significant improvements in image resolution and quality. However, many research efforts perceive generators as a black box and there is limited knowledge regarding the image generation process, controlling stochastic features in image diversity and the nature of the latent space. In response, researchers have commenced exploring the inner workings of generators.
The rise of StyleGAN is in direct reaction to this challenge. It modifies the generator network structure to improve the image generation process. Using a fixed, learned input, the generator adjusts the "style" of each convolutional layer to the underlying code for more direct image feature management. Moreover, StyleGAN can somewhat modify attributes and execute style blending or interpolation operations with noise injection. This approach permits researchers to gain a more in-depth comprehension of the image generation process and control model generation style.
Dong and his colleagues [20] employed a data enhancement method based on StyleGAN in their research to generate diverse types of pavement damage images without replacing the original dataset images. This technique enhanced the segmentation model's efficacy, as confirmed by Figure 4, which shows the model's architecture.
We selected several current open-source datasets of pavement cracks for constructing the asphalt pavement crack image dataset to improve the generalization performance. The dataset used in this paper includes transverse crack and longitudinal crack images from CrackForest, Crack500, Cracktree20, GAPs384 and AEL (Aigle-RN & ESAR & LCMS).
The CrackForest dataset is a database of road crack images that respond to the condition of urban pavements under general inspection conditions [21], and there are 156 images in total, which are filtered according to the acquisition of crack characteristics. Crack500 [22] dataset was derived from 500 photos taken by cell phones at Temple University. To fit the model input image pixel requirements and to facilitate model training, the original images are divided into non-overlapping image regions.CrackTree200 contains 206 pavement images with multiple types of cracks, along with lighting, noise and low contrast [23]. GAPs384 originated from the German asphalt pavement distress dataset, which is a large sample dataset of a high standard and contains a total of 1969 grayscale images that also contain different categories of cracks and potholes [24]. A total of 509 images of cracks were selected among them. AEL is the conditioned pavement image database obtained from different travel speeds [25].
The images used for the experiments in this paper are transverse cracks (1037 images) and longitudinal cracks (1107 images) of asphalt pavements. After converting them into inputs suitable for the model, the crack images that qualified by manual selection were counted as shown in Table 1.
Dataset | CrackForest | Crack500 | CrackTree200 | GAPs384 | AEL |
Image resolution | 480 × 320 | 2000 × 1500 | 800 × 600 | 1920 × 1080 | 800 × 800 |
Amount | 96 | 1071 | 595 | 325 | 57 |
Total | 2144 |
Furthermore, because the crack images in the selected dataset have different acquisition methods and road conditions, the images include different characteristics of background conditions and environmental conditions, and if the original images are not grayed out, many color information with low correlation to the crack morphology is learned in the subsequent network model, resulting in a serious distortion of the generated crack images. Therefore, this paper's images are grayed out to solve this issue.
In the unconditional Generative Adversarial Network [26] framework, the process of generating new data samples is essentially random, relying on inputs in the form of randomly generated noise vectors, as shown in Figure 2(a). This inherent randomness is valuable for generating diversity and presents significant challenges in terms of direct ability and precise control. Unlike conditional models that allow the manipulation of specific attributes, unconditional GANs do not provide explicit levers to influence the characteristics of the output, such as determining the specific type or style of the generated samples. Thus, while the model excels at generating a wide range of outputs, the lack of deterministic control mechanisms means that guiding the generative process to produce results with desired properties remains an elusive endeavor.
To address the limitations of unconditional GAN, a new version called conditional GAN has been introduced. This approach incorporates label information into the generation process, providing guidance for the model. With conditional GAN, both the generator and discriminator models are conditioned on these labels. This approach differs significantly from the traditional GAN as it relies on guidance during the generation process. Its advantage lies in its ability to produce data with specific properties. For instance, it can create images that fall within a certain category. This is a marked contrast to the arbitrary and unregulated results of unconditional GANs. Therefore, conditional GANs offer a potent means of regulating the generation process's intricacies, thereby augmenting GANs' practicality and versatility across different domains.
The application of cGANs extends beyond merely enlarging pavement disease datasets; it also includes generating class-specific data to address the imbalance in data clustering classes, which is a result of the rarity of certain diseases. Integrating with labels, cGANs can effectively produce data for specific types of pavement diseases, which is particularly important for addressing the imbalance of pavement disease types. In traditional datasets, some types of diseases may have less data due to their rarity, which hinders effective learning in model training and recognition processes. Using cGANs, we can generate more data for these rare disease types, thereby enhancing the model's recognition ability and accuracy, and ensuring effective identification and handling of various types of pavement diseases. In this way, cGANs provide an effective solution for balancing and enriching pavement disease datasets. Specific cases are listed below:
Tang et al. [27] proposed a fault diagnosis method based on the Wasserstein Generative Adversarial Network (WGAN-GP) and Convolutional Neural Network (CNN) for the problem of severe imbalance and distributional differences in fault data. Ten datasets of unbalanced states were used in the study and fed into five other deep-learning models for comparison experiments. Experimental results showed that this method achieved a fault diagnosis accuracy of 99.9% under the first data distribution condition, while the accuracies of the other six methods were 99.1, 98.9, 98.6, 97.8, 94.1 and 93.9%, respectively. When the number of training samples for each fault category was reduced to half of the normal sample count, this method's fault diagnosis accuracy far exceeded the other six methods, reaching 99.2%. We also found that as the data imbalance ratio increased, the diagnostic performance of each method significantly decreased. However, when the imbalance ratio reached 10: 1, this method exhibited good diagnostic performance. Therefore, although the fault identification accuracy of this method decreased with the increase in data imbalance ratio, it maintained high diagnostic accuracy and stability. This research provides an intelligent method for diagnosing rolling bearing faults and has proven its effectiveness and superiority in experiments.
The application of Conditional Generative Adversarial Networks (cGANs) is not limited to data generation. In fact, they can also be used for detecting road surface diseases. These networks, by learning various characteristics and patterns of pavement diseases, can effectively recognize and categorize different types of diseases. In the application of road disease detection, cGANs are capable of analyzing road images and identifying the presence and category of diseases. This is because cGANs can understand and mimic the characteristics of pavement diseases, thereby providing accurate identification during the actual detection process. This method is particularly effective for subtle or complex diseases that are difficult to identify through traditional methods. Thus, cGANs offer an efficient and accurate technological means for the detection and classification of road surface diseases, significantly improving the efficiency and effectiveness of pavement disease management and maintenance.
Kyslytsyna et al. [28] conducted a study on a road surface crack detection method based on Conditional Generative Adversarial Networks, proposing an automatic method to detect road surface cracks using deep learning technology. They trained a conditional generative adversarial network to generate cracks in real pavement images and compared them with actual images for the detection and localization of cracks. They mention existing crack detection methods but highlights issues with these methods in processing real-world images, such as high false-positive rates and sensitivity to lighting and shadows. To address these issues, they proposed a method based on Conditional Generative Adversarial Networks that can detect road surface cracks more accurately. The research team validated their method experimentally and compared it with other methods. The results showed that their method has high accuracy and robustness in crack detection. Additionally, they discussed the limitations and potential improvements of their approach. Overall, we present a road surface crack detection method based on Conditional Generative Adversarial Networks and demonstrates its effectiveness through experiments. This research is significant for road maintenance and safety, potentially enhancing the accuracy and efficiency of pavement crack detection.
One limitation of the traditional GAN is that if the input image is ambiguous, the model produces a random image and lacks the ability to determine the image class. The CGAN [29] enhances the original GAN by incorporating supplementary conditional data into the original network structure, resulting in a more objective function when compared to the traditional GAN, for both the discriminator and the generator input. From solving the binary game problem of minimal maximization between the generator and the discriminator, we progress to solving the minimal-maximal binary game problem with conditional probabilities. We use the CGAN model, as presented in Figure 5.
1) The Generator structure consists of four fully connected layers that require the input of conditional information and noise data, with a dimension of 100, to obtain the generated image.
2) The structure of the discriminator involves inputting condition information and image data and deriving the probability of image authenticity via four fully connected layers.
ACGAN [30] can be considered as a combination of DCGAN and CGAN. The network structure of ACGAN is shown in Figure 6. Feature extraction capability of convolution is used to improve the learning of the model.
1) Generator structure: The network has 5 layers, 4 convolutional layers and 1 fully connected layer. The input is set to random noise (variable) of 1 × 100 dimensions and satisfying uniform distribution. The image with a feature map of 4 × 4 × 1024 is obtained by the fully connected layer; the generated crack image is obtained by 4 times transposed convolution.
2) Discriminator structure: The input of the discriminator is the generated image and the real image, and the output is the probability of judging the authenticity of the image. The feature map is reduced by 4 times of convolution operation, and then the input image is true/false by a fully connected layer.
ACGAN makes the following improvements to the original CGAN. Eliminate all pooling layers. Except for the output layer of the generative network and the input layer of the discriminative network, both use BN (Batch Normalization) to handle the initialization problem. Eliminate the fully connected layer and transpose the 1 × 1 convolution to make the network a fully convolutional network. ReLU is used as the activation function in the generative network, tanh is used in the last layer and LeakyReLU is used as the generating function in the discriminative network.
Traditional convolutional GAN generates images very realistically on texture features but does not work well in generating geometric structure features. Due to the fixed size of the convolutional kernel in the convolutional neural network, only local features can be extracted, and geometric features that depend on global features may not be extracted when they appear. One method is to expand the perceptual field by increasing the number of layers of the network, which leads to an increment in model depth and training efficiency. Another approach is to increase the size of the convolutional kernel to enhance the perceptual field, but this approach increases the number of parameters and the training cost. For this reason, Zhang et al. [6] applied the self-attentive mechanism, which has been widely used in recent years, to obtain global features and thus enhance the geometric features of the generated images with less training cost.
The principle of the attention mechanism is shown in Figure 7 below, where Q (query), K (key) and V (value) are selected, and the probability distribution is obtained by matrix multiplication of Q and K by Softmax, which is then multiplied by V to obtain the self-attention value.
The self-attention mechanism implies that Q, K and V all originate from themselves and can be updated based on task training. Self-attentions are applied to the latter two layers of both discriminator and generator.
The network architecture of the generator consists of the following components: First, the generator receives a random noise vector and labels it as input. It uses a fractionally-strided convolution for up-sampling, combined with batch normalization and a ReLU activation function. This noise vector is converted into a larger feature map in multiple up-sampling layers, each using transposed convolution, batch normalization and the ReLU activation function. In addition, the generator contains two Self-Attention layers that help the model capture long-range dependencies in the image.
The discriminator part is initialized with down-sampling using ordinary convolutional layers with a LeakyReLU activation function. The features of the input image are progressively compressed in multiple down-sampling layers, each using convolution and LeakyReLU. The discriminator also contains two self-attention layers to improve the recognition of image details. Finally, the final layer of the discriminator uses convolution to convert the feature map into a score indicating the probability that the image is real.
Spectral normalization [6] is added for the generator and discriminator, which effectively reduces the computational effort of training and makes it more stable. The SAGAN network structure is shown in Figure 8 below.
In addition to the self-attention mechanism, the SAGAN in this paper applies Spectral Normalization to the weights of the generator and discriminator based on ACGAN, so that the discriminator satisfies the 1-Lipschitz condition, and avoids the gradient anomalies caused by too many parameters of the generator, making the whole training process more stable.
Images of asphalt pavement cracks generated by CGAN, ACGAN and SAGAN on a different number of iterations are shown in Figure 9 CGAN, ACGAN and SAGAN all use SGD optimizers with a generator learning rate of 0.0001, a discriminator learning rate of 0.0004 and a batch size uniformly set to 16. Among the images generated by each GAN model, the generated images of transverse cracks and longitudinal cracks are randomly selected at each iteration number for comparison. CGAN, ACGAN and SAGAN are shown with 100, 50 and 20 epochs as 1 stage, respectively.
The evaluation of the image generation effect was studied in this paper. There is currently no fixed and objective metric for the evaluation of images generated by conditional GAN, and the objective evaluation of the model generation effect is performed using common metrics in previous studies. Namely, the Inception Score (IS) and the FID (Fréchet Inception Distance) metrics for the original crack dataset used in this paper as well as the generated ones. The IS index is usually used to evaluate the GAN-generated images.
IS is usually used to evaluate the quality and diversity of the GAN-generated images using the score obtained on Inception Net-V3, and a high score usually indicates that the generated images meet the requirements. The Inception Score (IS) is a metric used to evaluate the quality of generated images. Its formula is defined as follows:
(3) |
represents the generated image, denotes the probability distribution of the predicted class y given the image x and the model, and p(y) is the marginal distribution of the predicted class . The IS determines the quality of the generated image by computing the divergence between the conditional class distribution and the marginal distribution . If the generated image entails discernible objects, the model's conditional class distribution output is likely to exhibit low entropy and proximity to the edge distribution. This, in turn, leads to a high IS score.
The FID distance score is a measure to calculate the distance between the feature vectors between the features of the real image and the generated image. It is calculated using the Inception v3 image classification model, and a low score means that the two sets of images are more similar, i.e., the GAN generates images that are similar to the real images. FID (Fréchet Inception Distance) [31] is another measure of the quality of the generated image, which is calculated as.
(4) |
where and represent the distribution of the generated image and the real image respectively, and Σ are the mean and covariance matrices of the features extracted by the Inception-v3 [32] model, respectively. FID evaluates the quality of the generated image by calculating the statistical difference between the mean and covariance matrices of the features of the two, and the lower the score of FID, the lower the visual differentiation between the generated image and the real image. Where x and y represent the distribution of the generated image and the real image, respectively. and Σ denote the mean and covariance matrices of the features extracted by the Inception-v3 model. The quality of the generated image is evaluated by FID, which calculates the statistical difference between the mean and covariance matrices of the features of both images. The lower the score of FID, the lower the visual differentiation between the generated and real image.
From Figure 9, it can be seen that when iterating to stage 1, CGAN just has traces of cracks, ACGAN appears as the outline of cracks and SAGAN appears as the location of cracks, all of which are in a serious and distorted degree of meshing at this time. When the iteration is at stage 2, CGAN does not show the crack outline, ACGAN, and SAGAN show the crack outline and the meshing problem is improving. When iterating at stage 3, CGAN cracks are still not ideal, ACGAN and SAGAN crack outlines are clearer, and the gridding problem is greatly improved. when iterating at stage 4, CGAN shows crack outlines, ACGAN and SAGAN generate images with slightly blurred backgrounds, but the crack theory opening has taken shape. at stage 5, CGAN starts to involve the difference between background and crack. At stage 5, CGAN starts to involve the difference between the background and the crack.
The evaluation of the image generation effect was studied in this paper. The Inception Score (IS) values for longitudinal and transverse cracks in the original images are 2.45 ± 0.11 and 1.98 ± 0.09, respectively. Data from Table 2 shows that SAGAN significantly outperforms both CGAN and ACGAN in generating images of longitudinal and transverse cracks. The high IS values (1.73 ± 0.05 and 1.59 ± 0.07) of SAGAN, along with its low Frechet Inception Distance (FID) values (71.29 and 68.01), suggest its superior capability in rendering more realistic and diverse crack images.
CGAN | ACGAN | SAGAN | ||||
Type of cracks | Longitudinal Crack | Transverse Crack | Longitudinal Crack | Transverse Crack | Longitudinal Crack | Transverse Crack |
IS | 1.44 ±0.03 | 1.33 ±0.06 | 1.61 ±0.04 | 1.46 ±0.05 | 1.73 ±0.05 | 1.59 ±0.07 |
FID | 133.76 | 124.06 | 81.15 | 73.73 | 71.29 | 68.01 |
This superiority is likely attributed to SAGAN's implementation of a self-attention mechanism, which enhances its ability to process global information and manage long-range dependencies in images, a critical aspect of pavement crack analysis. By analyzing the experimental results, we found that the generative performance advantages of SAGAN have great potential to be a beneficial tool, assisting road engineers in high-quality construction and more balanced pavement disease detection datasets.
The analysis also reveals a consistent pattern across all tested conditional GANs: IS values for longitudinal cracks are higher than those for transverse cracks, while FID values show an inverse relationship. This indicates a general trend in the models' capabilities, where longitudinal cracks are rendered with high quality and diversity, more closely resembling real images. Such a trend might stem from the intrinsic differences in the complexity or visual features of longitudinal versus transverse cracks.
While these results confirm the effectiveness of SAGAN in pavement crack image processing, they also open avenues for further research. It is crucial to delve deeper into the reasons why SAGAN outperforms its counterparts. Factors such as the quantity and quality of training data, the architectural nuances of the model and the specifics of the training process can influence the performance. Moreover, aligning these findings with existing theories in image processing and GANs can provide valuable insights into the model's behavior.
For practical deployment, understanding these dynamics is crucial. It can guide the development of more refined models for pavement crack detection, contributing to more efficient and accurate maintenance strategies in urban planning and infrastructure management. Future research directions might focus on experimenting with varied training datasets, tweaking model architectures and exploring hybrid models that combine the strengths of different GANs to enhance image generation quality for specific types of pavement cracks.
For the limited number of current pavement-specific field crack images, we carried out the optimal design of the GAN model from crack dataset augmentation using public datasets.
1) The GAN was designed based on the structure of fully connected, convolutional and attention mechanisms, and it was demonstrated subjectively and objectively that the use of attention mechanisms can improve the quality and diversity of the images generated by the GAN, which are more similar in content to the original crack image dataset.
2) By integrating the structure of CGAN within SAGAN and its self-attention mechanisms, this method has partially solved the problem of GANs being unable to generate category-specific images, while also enhancing the quality of image rendering. The approach presented in this paper is not only applicable for expanding the pavement disease image dataset but also addresses the issue of imbalanced class samples within the dataset. This enhancement in dataset quality ensures the accuracy of subsequent identification and detection tasks.
The results demonstrate that the conditional GAN with the self-attention mechanism produces high-quality pavement crack images, such as increased detail, clarity and realism. This improvement in image quality is a significant advantage and can potentially benefit applications related to road maintenance and safety. However, the self-attention mechanism demands considerable computational resources. To optimize and accelerate the model's performance, we plan to simplify the network structure, refine parameters and compress the model.
The authors declare that they have not used artificial intelligence tools in the creation of this article.
The authors appreciate the financial support from Hunan Expressway Group Co. Ltd and the Hunan Department of Transportation (No. 202152) in China. The authors also appreciate the funding support from Beijing's high-level overseas talents. All opinions, findings and conclusions expressed in this paper are those of the authors and do not necessarily represent the view of any organization.
The authors declare that there are no conflicts of interest.
[1] |
Zhou P, Yang XL, Wang XG, et al. (2020) A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature 579: 270-273. https://doi.org/10.1038/s41586-020-2012-7 ![]() |
[2] |
Han X, Xu P, Ye Q (2021) Analysis of COVID-19 vaccines: Types, thoughts, and application. J Clin Lab Anal 35: e23937. https://doi.org/10.1002/jcla.23937 ![]() |
[3] |
Yadav T, Kumar S, Mishra G, et al. (2023) Tracking the COVID-19 vaccines: The global landscape. Hum Vaccin Immunother 19: 2191577. https://doi.org/10.1080/21645515.2023.2191577 ![]() |
[4] |
Shoaib MH, Ahmed FR, Sikandar M, et al. (2021) A Journey From SARS-CoV-2 to COVID-19 and Beyond: A Comprehensive Insight of Epidemiology, Diagnosis, Pathogenesis, and Overview of the Progress into Its Therapeutic Management. Front Pharmacol 12: 576448. https://doi.org/10.3389/fphar.2021.576448 ![]() |
[5] |
Tai W, Zhang X, Yang Y, et al. (2022) Advances in mRNA and other vaccines against MERS-CoV. Transl Res 242: 20-37. https://doi.org/10.1016/j.trsl.2021.11.007 ![]() |
[6] |
Lundstrom K (2021) Viral vectors for COVID-19 vaccine development. Viruses 13: 317. https://doi.org/10.3390/v13020317 ![]() |
[7] |
Khoshnood S, Arshadi M, Akrami S, et al. (2022) An overview on inactivated and live-attenuated SARS-CoV-2 vaccines. J Clin Lab Anal 36: e24418. https://doi.org/10.1002/jcla.24418 ![]() |
[8] |
Fathizadeh H, Afshar S, Masoudi MR, et al. (2021) SARS-CoV-2 (Covid-19) vaccines structure, mechanisms and effectiveness: A review. Int J Biol Macromol 188: 740-750. https://doi.org/10.1016/j.ijbiomac.2021.08.076 ![]() |
[9] |
Heidary M, Kaviar VH, Shirani M, et al. (2022) A comprehensive review of the protein subunit vaccines against COVID-19. Front Microbiol 13: 927306. https://doi.org/10.3389/fmicb.2022.927306 ![]() |
[10] |
Nyon MP, Du L, Tseng CK, et al. (2018) Engineering a stable CHO cell line for the expression of a MERS-coronavirus vaccine antigen. Vaccine 36: 1853-1862. https://doi.org/10.1016/j.vaccine.2018.02.065 ![]() |
[11] |
Mohapatra PR, Mishra B, Behera B (2021) BCG vaccination induced protection from COVID-19. Indian J Tuberc 68: 119-124. https://doi.org/10.1016/j.ijtb.2020.08.004 ![]() |
[12] |
Seif F, Aazami H, Khoshmirsafa M, et al. (2020) JAK Inhibition as a New Treatment Strategy for Patients with COVID-19. Int Arch Allergy Immunol 181: 467-475. https://doi.org/10.1159/000508247 ![]() |
[13] |
Hosseini N, Nadjafi S, Ashtary B (2021) Overview of COVID-19 and neurological complications. Rev Neurosci 32: 671-691. https://doi.org/10.1515/revneuro-2020-0116 ![]() |
[14] | Ogidi OI, Berefagha WL, Okara E (2021) Covid-19 vaccination: the pros and cons. World J Biol Pharm Health Sci 7: 015-022. https://doi.org/10.30574/wjbphs.2021.7.1.0072 |
[15] |
Frontera JA, Tamborska AA, Doheim MF, et al. (2022) Neurological Events Reported after COVID-19 Vaccines: An Analysis of VAERS. Ann Neurol 91: 756-771. https://doi.org/10.1002/ana.26339 ![]() |
[16] |
Khayat-Khoei M, Bhattacharyya S, Katz J, et al. (2020) COVID-19 mRNA vaccination leading to CNS inflammation: a case series. J Neurol 269: 1093-1106. https://doi.org/10.1007/s00415-021-10780-7 ![]() |
[17] |
Sriwastava S, Sharma K, Khalid SH, et al. (2022) COVID-19 Vaccination and Neurological Manifestations: A Review of Case Reports and Case Series. Brain Sci 12: 407. https://doi.org/10.3390/brainsci12030407 ![]() |
[18] |
AlKolfat F, Elfatatry A, Mekky J, et al. (2022) Combined peripheral and central nervous system demyelination post-COVID-19 vaccination: A case report. Neuroimmunol Rep 2: 100057. https://doi.org/10.1016/j.nerep.2022.100057 ![]() |
[19] |
Patone M, Handunnetthi L, Saatci D, et al. (2021) Neurological complications after first dose of COVID-19 vaccines and SARS-CoV-2 infection. Nat Med 27: 2144-2153. https://doi.org/10.1038/s41591-021-01556-7 ![]() |
[20] |
Vogrig A, Tartaglia S, Dentoni M, et al. (2024) Central nervous system immune-related disorders after SARS-CoV-2 vaccination: a multicenter study. Front Immunol 15: 1344184. https://doi.org/10.3389/fimmu.2024.1344184 ![]() |
[21] |
Mendoza S (2023) Adapting patient treatment of neurological diseases during the COVID-19 pandemic. AIMS Neurosci 10: 75-86. https://doi.org/10.3934/Neuroscience.2023006 ![]() |
[22] |
Sungnak W, Huang N, Bécavin C, et al. (2020) SARS-CoV-2 entry factors are highly expressed in nasal epithelial cells together with innate immune genes. Nat Med 26: 681-687. https://doi.org/10.1038/s41591-020-0868-6 ![]() |
[23] |
Roshanravan N, Seif F, Ostadrahimi A, et al. (2020) Targeting Cytokine Storm to Manage Patients with COVID-19: A Mini-Review. Arch Med Res 51: 608-612. https://doi.org/10.1016/j.arcmed.2020.06.012 ![]() |
[24] |
Bahrami M, Kamalinejad M, Latifi SA, et al. (2020) Cytokine storm in COVID-19 and parthenolide: Preclinical evidence. Phytother Res 34: 2429-2430. https://doi.org/10.1002/ptr.6776 ![]() |
[25] |
Thiel V, Weber F (2008) Interferon and cytokine responses to SARS-coronavirus infection. Cytokine Growth Factor Rev 19: 121-132. https://doi.org/10.1016/j.cytogfr.2008.01.001 ![]() |
[26] |
Hu W, Yen YT, Singh S, et al. (2012) SARS-CoV regulates immune function-related gene expression in human monocytic cells. Viral Immunol 25: 277-288. https://doi.org/10.1089/vim.2011.0099 ![]() |
[27] |
Wang P (2021) Significance of IgA antibody testing for early detection of SARS-CoV-2. J Med Virol 93: 1888-1889. https://doi.org/10.1002/jmv.26703 ![]() |
[28] |
Shah VK, Firmal P, Alam A, et al. (2020) Overview of Immune Response During SARS-CoV-2 Infection: Lessons From the Past. Front Immunol 11: 1949. https://doi.org/10.3389/fimmu.2020.01949 ![]() |
[29] |
Lineburg KE, Grant EJ, Swaminathan S, et al. (2021) CD8+ T cells specific for an immunodominant SARS-CoV-2 nucleocapsid epitope cross-react with selective seasonal coronaviruses. Immunity 54: 1055-1065.e5. https://doi.org/10.1016/j.immuni.2021.04.006 ![]() |
[30] |
Grifoni A, Weiskopf D, Ramirez SI, et al. (2020) Targets of T Cell Responses to SARS-CoV-2 Coronavirus in Humans with COVID-19 Disease and Unexposed Individuals. Cell 181: 1489-1501.e15. https://doi.org/10.1016/j.cell.2020.05.015 ![]() |
[31] |
Nezhad MS, Seif F, Darazam IA, et al. (2020) An overview of the prominence of current diagnostic methods for diagnosis of COVID-19. AIMS Allergy Immunol 4: 60-74. https://doi.org/10.3934/Allergy.2020006 ![]() |
[32] |
Iwasaki A, Yang Y (2020) The potential danger of suboptimal antibody responses in COVID-19. Nat Rev Immunol 20: 339-341. https://doi.org/10.1038/s41577-020-0321-6 ![]() |
[33] | Ricke D, Malone RW Medical countermeasures analysis of 2019-nCoV and vaccine risks for antibody-dependent enhancement (ADE) (2020). Available from: https://www.preprints.org/manuscript/202003.0138/v1/download |
[34] |
Kumar BV, Connors TJ, Farber DL (2018) Human T Cell Development, Localization, and Function throughout Life. Immunity 48: 202-213. https://doi.org/10.1016/j.immuni.2018.01.007 ![]() |
[35] |
Li CK, Wu H, Yan H, et al. (2008) T cell responses to whole SARS coronavirus in humans. J Immunol 181: 5490-5500. https://doi.org/10.4049/jimmunol.181.8.5490 ![]() |
[36] |
Khan WH, Hashmi Z, Goel A, et al. (2021) COVID-19 Pandemic and Vaccines Update on Challenges and Resolutions. Front Cell Infect Microbiol 11: 690621. https://doi.org/10.3389/fcimb.2021.690621 ![]() |
[37] |
Yap C, Ali A, Prabhakar A, et al. (2021) Comprehensive literature review on COVID-19 vaccines and role of SARS-CoV-2 variants in the pandemic. Ther Adv Vaccines Immunother 9: 25151355211059791. https://doi.org/10.1177/25151355211059791 ![]() |
[38] |
Murata K, Nakao N, Ishiuchi N, et al. (2022) Four cases of cytokine storm after COVID-19 vaccination: Case report. Front Immunol 13: 967226. https://doi.org/10.3389/fimmu.2022.967226 ![]() |
[39] |
Muvenda T, Williams AA, Williams ME (2024) Transactivator of Transcription (Tat)-Induced Neuroinflammation as a Key Pathway in Neuronal Dysfunction: A Scoping Review. Mol Neurobiol 61: 9320-9346. https://doi.org/10.1007/s12035-024-04173-w ![]() |
[40] |
Kahn B, Apostolidis SA, Bhatt V, et al. (2021) Multisystem Inflammation and Organ Dysfunction After BNT162b2 Messenger RNA Coronavirus Disease 2019 Vaccination. Crit Care Explor 3: e0578. https://doi.org/10.1097/CCE.0000000000000578 ![]() |
[41] |
Rasquinha MT, Sur M, Lasrado N, et al. (2021) IL-10 as a Th2 Cytokine: Differences Between Mice and Humans. J Immunol 207: 2205-2215. https://doi.org/10.4049/jimmunol.2100565 ![]() |
[42] |
Konnova A, De Winter FH, Gupta A, et al. (2022) Predictive model for BNT162b2 vaccine response in cancer patients based on blood cytokines and growth factors. Front Immunol 13: 1062136. ![]() |
[43] |
Paredes-Vazquez JG, Rubio-Infante N, Lopez-de la Garza H, et al. (2023) Soluble factors in COVID-19 mRNA vaccine-induced myocarditis causes cardiomyoblast hypertrophy and cell injury: a case report. Virol J 20: 203. https://doi.org/10.1186/s12985-023-02120-0 ![]() |
[44] |
Varghese M, Alsoub HARS, Koleri J, et al. (2022) Multisystem inflammatory syndrome in children (MIS-C) secondary to COVID-19 mRNA vaccination - A case report from Qatar. IDCases 30: e01606. https://doi.org/10.1016/j.idcr.2022.e01606 ![]() |
[45] |
Assiri SA, Althaqafi RMM, Alswat K, et al. (2022) Post COVID-19 Vaccination-Associated Neurological Complications. Neuropsychiatr Dis Treat 18: 137-154. https://doi.org/10.2147/NDT.S343438 ![]() |
[46] |
Gruol DL, Nelson TE (1997) Physiological and pathological roles of interleukin-6 in the central nervous system. Mol Neurobiol 15: 307-339. https://doi.org/10.1007/BF02740665 ![]() |
[47] | Hewett SJ, Jackman NA, Claycomb RJ (2012) Interleukin-1β in Central Nervous System Injury and Repair. Eur J Neurodegener Dis 1: 195-211. |
[48] |
Nyati KK, Prasad KN, Kharwar NK, et al. (2012) Immunopathology and Th1/Th2 immune response of Campylobacter jejuni-induced paralysis resembling Guillain-Barré syndrome in chicken. Med Microbiol Immunol 201: 177-187. https://doi.org/10.1007/s00430-011-0220-3 ![]() |
[49] |
Sutinen EM, Korolainen MA, Häyrinen J, et al. (2014) Interleukin-18 alters protein expressions of neurodegenerative diseases-linked proteins in human SH-SY5Y neuron-like cells. Front Cell Neurosci 8: 214. https://doi.org/10.3389/fncel.2014.00214 ![]() |
[50] |
Waisman A, Hauptmann J, Regen T (2015) The role of IL-17 in CNS diseases. Acta Neuropathol 129: 625-637. https://doi.org/10.1007/s00401-015-1402-7 ![]() |
[51] |
Peerlings D, Mimpen M, Damoiseaux J (2021) The IL-2 - IL-2 receptor pathway: Key to understanding multiple sclerosis. J Transl Autoimmun 4: 100123. https://doi.org/10.1016/j.jtauto.2021.100123 ![]() |
[52] |
Boven LA, Montagne L, Nottet HS, et al. (2000) Macrophage inflammatory protein-1alpha (MIP-1alpha), MIP-1beta, and RANTES mRNA semiquantification and protein expression in active demyelinating multiple sclerosis (MS) lesions. Clin Exp Immunol 122: 257-263. https://doi.org/10.1046/j.1365-2249.2000.01334.x ![]() |
[53] |
Quist-Paulsen E, Aukrust P, Kran AB, et al. (2018) High neopterin and IP-10 levels in cerebrospinal fluid are associated with neurotoxic tryptophan metabolites in acute central nervous system infections. J Neuroinflammation 15: 327. https://doi.org/10.1186/s12974-018-1366-3 ![]() |
[54] |
Ghosh R, Dubey S, Roy D, et al. (2021) Focal onset non-motor seizure following COVID-19 vaccination: A mere coincidence?. Diabetes Metab Syndr 15: 1023-1024. https://doi.org/10.1016/j.dsx.2021.05.003 ![]() |
[55] |
Hosseini R, Askari N (2023) A review of neurological side effects of COVID-19 vaccination. Eur J Med Res 28: 102. https://doi.org/10.1186/s40001-023-00992-0 ![]() |
[56] |
Fan HT, Lin YY, Chiang WF, et al. (2022) COVID-19 vaccine-induced encephalitis and status epilepticus. QJM 115: 91-93. https://doi.org/10.1093/qjmed/hcab335 ![]() |
[57] |
Markus H (2016) Stroke: causes and clinical features. Medicine 44: 515-520. https://doi.org/10.1016/j.mpmed.2016.06.006 ![]() |
[58] |
Parikh NS, Merkler AE, Iadecola C (2020) Inflammation, Autoimmunity, Infection, and Stroke: Epidemiology and Lessons From Therapeutic Intervention. Stroke 51: 711-718. https://doi.org/10.1161/STROKEAHA.119.024157 ![]() |
[59] |
Mohseni Afshar Z, Sharma A, Babazadeh A, et al. (2023) A review of the potential neurological adverse events of COVID-19 vaccines. Acta Neurol Belg 123: 9-44. https://doi.org/10.1007/s13760-022-02137-2 ![]() |
[60] |
Wise J (2024) Covid-19: Two rare vaccine side effects detected in large global study. BMJ 384: q488. https://doi.org/10.1136/bmj.q488 ![]() |
[61] |
Ahmad SA, Abbas YN, Ahmed JO, et al. (2023) Neurological Adverse Effects Following Administration of COVID-19 Vaccination: A Meta-Analysis. Indian J Clin Med 13: 24-33. https://doi.org/10.1177/26339447221139021 ![]() |
[62] |
Jabagi MJ, Botton J, Bertrand M, et al. (2022) Myocardial Infarction, Stroke, and Pulmonary Embolism After BNT162b2 mRNA COVID-19 Vaccine in People Aged 75 Years or Older. JAMA 327: 80-82. https://doi.org/10.1001/jama.2021.21699 ![]() |
[63] |
Barda N, Dagan N, Ben-Shlomo Y, et al. (2021) Safety of the BNT162b2 mRNA Covid-19 Vaccine in a Nationwide Setting. N Engl J Med 385: 1078-1090. https://doi.org/10.1056/NEJMoa2110475 ![]() |
[64] |
Klein NP, Lewis N, Goddard K, et al. (2021) Surveillance for Adverse Events After COVID-19 mRNA Vaccination. JAMA 326: 1390-1399. https://doi.org/10.1001/jama.2021.15072 ![]() |
[65] |
Yang Y, Huang L (2023) Neurological Disorders following COVID-19 Vaccination. Vaccines (Basel) 11: 1114. https://doi.org/10.3390/vaccines11061114 ![]() |
[66] |
Mendez-Lizarraga CA, Chacon-Cruz E, Carrillo-Meza R, et al. (2022) Report of Adverse Effects Following Population-Wide COVID-19 Vaccination: A Comparative Study between Six Different Vaccines in Baja-California, Mexico. Vaccines (Basel) 10: 1196. https://doi.org/10.3390/vaccines10081196 ![]() |
[67] |
Nahab F, Bayakly R, Sexton ME, et al. (2023) Factors associated with stroke after COVID-19 vaccination: a statewide analysis. Front Neurol 14: 1199745. https://doi.org/10.3389/fneur.2023.1199745 ![]() |
[68] |
López-Mena D, García-Grimshaw M, Saldivar-Dávila S, et al. (2022) Stroke Among SARS-CoV-2 Vaccine Recipients in Mexico: A Nationwide Descriptive Study. Neurology 98: e1933-e1941. https://doi.org/10.1212/WNL.0000000000200388 ![]() |
[69] |
Hidayat R, Diafiri D, Zairinal RA, et al. (2021) Acute Ischaemic Stroke Incidence after Coronavirus Vaccine in Indonesia: Case Series. Curr Neurovasc Res 18: 360-363. https://doi.org/10.2174/1567202618666210927095613 ![]() |
[70] |
Aladdin Y, Shirah B (2021) New-onset refractory status epilepticus following the ChAdOx1 nCoV-19 vaccine. J Neuroimmunol 357: 577629. https://doi.org/10.1016/j.jneuroim.2021.577629 ![]() |
[71] |
Elaidouni G, Chetouani Z, Manal Merbouh CB, et al. (2022) Acute ischemic stroke after first dose of inactivated COVID-19 vaccine: A case report. Radiol Case Rep 17: 1942-1945. https://doi.org/10.1016/j.radcr.2022.02.082 ![]() |
[72] |
Eslait-Olaciregui S, Llinás-Caballero K, Patiño-Manjarrés D, et al. (2023) Serious neurological adverse events following immunization against SARS-CoV-2: a narrative review of the literature. Ther Adv Drug Saf 14: 20420986231165674. https://doi.org/10.1177/20420986231165674 ![]() |
[73] |
Taquet M, Husain M, Geddes JR, et al. (2021) Cerebral venous thrombosis and portal vein thrombosis: A retrospective cohort study of 537,913 COVID-19 cases. EClinicalMedicine 39: 101061. https://doi.org/10.1016/j.eclinm.2021.101061 ![]() |
[74] |
Chemaitelly H, Akhtar N, Jerdi SA, et al. (2024) Association between COVID-19 vaccination and stroke: a nationwide case-control study in Qatar. Int J Infect Dis 145: 107095. https://doi.org/10.1016/j.ijid.2024.107095 ![]() |
[75] | Yadegarynia D, Tehrani S, Hadavand F, et al. (2023) Side effects after COVID-19 vaccination: a comparison between the most common available vaccines in Iran. Iran J Microbio 15: 189-195. https://doi.org/10.18502/ijm.v15i2.12467 |
[76] |
Masoudian N, Kakovan M, Shirkouhi SG, et al. (2023) Ischemic stroke following COVID-19 vaccination. J Res Clin Med 11: 33. https://doi.org/10.34172/jrcm.2023.33321 ![]() |
[77] |
Ishizu T, Minohara M, Ichiyama T, et al. (2006) CSF cytokine and chemokine profiles in acute disseminated encephalomyelitis. J Neuroimmunol 175: 52-58. https://doi.org/10.1016/j.jneuroim.2006.03.020 ![]() |
[78] |
Maramattom BV, Lotlikar RS, Sukumaran S (2022) Central nervous system adverse events after ChAdOx1 vaccination. Neurol Sci 43: 3503-3507. https://doi.org/10.1007/s10072-022-06000-3 ![]() |
[79] |
Morgan HJ, Clothier HJ, Sepulveda Kattan G, et al. (2024) Acute disseminated encephalomyelitis and transverse myelitis following COVID-19 vaccination - A self-controlled case series analysis. Vaccine 42: 2212-2219. https://doi.org/10.1016/j.vaccine.2024.01.099 ![]() |
[80] |
Nabizadeh F, Noori M, Rahmani S, et al. (2023) Acute disseminated encephalomyelitis (ADEM) following COVID-19 vaccination: A systematic review. J Clin Neurosci 111: 57-70. https://doi.org/10.1016/j.jocn.2023.03.008 ![]() |
[81] |
Stoian A, Bajko Z, Stoian M, et al. (2023) The Occurrence of Acute Disseminated Encephalomyelitis in SARS-CoV-2 Infection/Vaccination: Our Experience and a Systematic Review of the Literature. Vaccines (Basel) 11: 1225. https://doi.org/10.3390/vaccines11071225 ![]() |
[82] |
Tagliaferri AR, Horani G, Stephens K, et al. (2021) A rare presentation of undiagnosed multiple sclerosis after the COVID-19 vaccine. J Community Hosp Intern Med Perspect 11: 772-775. https://doi.org/10.1080/20009666.2021.1979745 ![]() |
[83] | Palle P, Monaghan KL, Milne SM, et al. (2017) Cytokine Signaling in Multiple Sclerosis and Its Therapeutic Applications. Med Sci (Basel) 5: 23. https://doi.org/10.3390/medsci5040023 |
[84] |
Soldan SS, Alvarez Retuerto AI, Sicotte NL, et al. (2004) Dysregulation of IL-10 and IL-12p40 in secondary progressive multiple sclerosis. J Neuroimmunol 146: 209-215. https://doi.org/10.1016/j.jneuroim.2003.10.033 ![]() |
[85] |
Ghafouri-Fard S, Honarmand K, Taheri M (2021) A comprehensive review on the role of chemokines in the pathogenesis of multiple sclerosis. Metab Brain Dis 36: 375-406. https://doi.org/10.1007/s11011-020-00648-6 ![]() |
[86] |
Samim MM, Dhar D, Arshad F, et al. (2023) Co-VAN study: COVID-19 vaccine associated neurological diseases- an experience from an apex neurosciences centre and review of the literature. J Clin Neurosci 108: 37-75. https://doi.org/10.1016/j.jocn.2022.12.015 ![]() |
[87] | Simone CG, Emmady PD (2025) Transverse Myelitis. Treasure Island (FL): StatPearls Publishing. |
[88] |
Weldon WC, Zhao K, Jost HA, et al. (2020) Cytokine biomarkers associated with clinical cases of acute flaccid myelitis. J Clin Virol 131: 104591. https://doi.org/10.1016/j.jcv.2020.104591 ![]() |
[89] |
Krishnan C, Kaplin AI, Deshpande DM, et al. (2004) Transverse Myelitis: pathogenesis, diagnosis and treatment. Front Biosci 9: 1483-1499. https://doi.org/10.2741/1351 ![]() |
[90] |
Tanaka M, Matsushita T, Tateishi T, et al. (2008) Distinct CSF cytokine/chemokine profiles in atopic myelitis and other causes of myelitis. Neurology 71: 974-981. https://doi.org/10.1212/01.wnl.0000326589.57128.c3 ![]() |
[91] |
Wu Q, Wang Q, Yang J, et al. (2021) Elevated sCD40L in Secondary Progressive Multiple Sclerosis in Comparison to Non-progressive Benign and Relapsing Remitting Multiple Sclerosis. J Cent Nerv Syst Dis 13: 11795735211050712. https://doi.org/10.1177/11795735211050712 ![]() |
[92] |
Corrêa DG, Cañete LAQ, Dos Santos GAC, et al. (2021) Neurological symptoms and neuroimaging alterations related with COVID-19 vaccine: Cause or coincidence?. Clin Imaging 80: 348-352. https://doi.org/10.1016/j.clinimag.2021.08.021 ![]() |
[93] |
Li X, Raventós B, Roel E, et al. (2022) Association between covid-19 vaccination, SARS-CoV-2 infection, and risk of immune mediated neurological events: population based cohort and self-controlled case series analysis. BMJ 376: e068373. https://doi.org/10.1136/bmj-2021-068373 ![]() |
[94] |
Madike R, Lee A (2023) A case of acute transverse myelitis following the AstraZeneca COVID-19 vaccine. Global J Med Clin Case Rep 10: 011-012. https://doi.org/10.17352/2455-5282.000169 ![]() |
[95] |
Pagenkopf C, Südmeyer M (2021) A case of longitudinally extensive transverse myelitis following vaccination against Covid-19. J Neuroimmunol 358: 577606. https://doi.org/10.1016/j.jneuroim.2021.577606 ![]() |
[96] |
Malhotra HS, Gupta P, Prabhu V, et al. (2021) COVID-19 vaccination-associated myelitis. QJM 114: 591-593. https://doi.org/10.1093/qjmed/hcab069 ![]() |
[97] |
Knoll MD, Wonodi C (2021) Oxford-AstraZeneca COVID-19 vaccine efficacy. Lancet 397: 72-74. https://doi.org/10.1016/S0140-6736(20)32623-4 ![]() |
[98] |
Medavarapu S, Goyal N, Anziska Y (2024) Acute transverse myelitis (ATM) associated with COVID 19 infection and vaccination: A case report and literature review. AIMS Neurosci 11: 178-187. https://doi.org/10.3934/Neuroscience.2024011 ![]() |
[99] |
Faksova K, Walsh D, Jiang Y, et al. (2024) COVID-19 vaccines and adverse events of special interest: A multinational Global Vaccine Data Network (GVDN) cohort study of 99 million vaccinated individuals. Vaccine 42: 2200-2211. https://doi.org/10.1016/j.vaccine.2024.01.100 ![]() |
[100] |
Hoorbakht H, Bagherkashi F (2012) Optic neuritis, its differential diagnosis and management. Open Ophthalmol J 6: 65-72. https://doi.org/10.2174/1874364101206010065 ![]() |
[101] |
Deckert-Schlüter M, Schlüter D, Schwendemann G (1992) Evaluation of IL-2, sIL2R, IL-6, TNF-alpha, and IL-1 beta levels in serum and CSF of patients with optic neuritis. J Neurol Sci 113: 50-54. https://doi.org/10.1016/0022-510x(92)90264-l ![]() |
[102] |
Pau D, Al Zubidi N, Yalamanchili S, et al. (2011) Optic neuritis. Eye (Lond) 25: 833-842. https://doi.org/10.1038/eye.2011.81 ![]() |
[103] |
Haseeb AA, Solyman O, Abushanab MM, et al. (2022) Ocular Complications Following Vaccination for COVID-19: A One-Year Retrospective. Vaccines (Basel) 10: 342. https://doi.org/10.3390/vaccines10020342 ![]() |
[104] |
Maleki A, Look-Why S, Manhapra A, et al. (2021) COVID-19 Recombinant mRNA Vaccines and Serious Ocular Inflammatory Side Effects: Real or Coincidence?. J Ophthalmic Vis Res 16: 490-501. https://doi.org/10.18502/jovr.v16i3.9443 ![]() |
[105] |
Elnahry AG, Asal ZB, Shaikh N, et al. (2023) Optic neuropathy after COVID-19 vaccination: a report of two cases. Int J Neurosci 133: 901-907. https://doi.org/10.1080/00207454.2021.2015348 ![]() |
[106] |
Moretti GTT, Fabiani G, Ferreira GME, et al. (2024) Multiple sclerosis and optic neuritis triggered by COVID-19 mRNA. Neuroimmunol Rep 5: 100198. ![]() |
[107] |
Copland E, Patone M, Saatci D, et al. (2024) Safety outcomes following COVID-19 vaccination and infection in 5.1 million children in England. Nat Commun 15: 3822. https://doi.org/10.1038/s41467-024-47745-z ![]() |
[108] |
Graus F, Titulaer MJ, Balu R, et al. (2016) A clinical approach to diagnosis of autoimmune encephalitis. Lancet Neurol 15: 391-404. https://doi.org/10.1016/S1474-4422(15)00401-9 ![]() |
[109] |
Chhatbar C, Prinz M (2021) The roles of microglia in viral encephalitis: from sensome to therapeutic targeting. Cell Mol Immunol 18: 250-258. https://doi.org/10.1038/s41423-020-00620-5 ![]() |
[110] |
Soltani Khaboushan A, Pahlevan-Fallahy MT, Shobeiri P, et al. (2022) Cytokines and chemokines profile in encephalitis patients: A meta-analysis. PLoS One 17: e0273920. https://doi.org/10.1371/journal.pone.0273920 ![]() |
[111] |
Garg RK, Paliwal VK (2022) Spectrum of neurological complications following COVID-19 vaccination. Neurol Sci 43: 3-40. https://doi.org/10.1007/s10072-021-05662-9 ![]() |
[112] | Liu BD, Ugolini C, Jha P (2021) Two Cases of Post-Moderna COVID-19 Vaccine Encephalopathy Associated With Nonconvulsive Status Epilepticus. Cureus 13: e16172. https://doi.org/10.7759/cureus.16172 |
[113] |
Kim JH, Yoon D, Ko HY, et al. (2024) Risk of encephalitis and meningitis after COVID-19 vaccination in South Korea: a self-controlled case series analysis. BMC Med 22: 123. https://doi.org/10.1186/s12916-024-03347-6 ![]() |
[114] |
Lopez-Gonzalez R, Otalvaro-Rendon MA, Quintero-Gutierrez L (2024) Encephalitis after COVID-19 vaccination. Neurologia (Engl Ed) 39: 716-719. https://doi.org/10.1016/j.nrleng.2024.02.002 ![]() |
[115] | Ebadi Z, Ghadiri F, Asadollahzade E, et al. (2022) Herpes simplex encephalitis after receiving COVID-19 vaccine; a case report. Front Emerg Med 6: e56. https://doi.org/10.18502/fem.v6i4.10443 |
[116] |
Abdelhady M, Husain MA, Hawas Y, et al. (2023) Encephalitis following COVID-19 Vaccination: A Systematic Review. Vaccines (Basel) 11: 576. https://doi.org/10.3390/vaccines11030576 ![]() |
[117] |
Mansour K, Chadli Z, Ghachem I, et al. (2023) Seronegative acute encephalitis following COVID-19 vaccines: a case series of an overlooked diagnosis with literature review. Eur J Clin Pharmacol 79: 975-987. https://doi.org/10.1007/s00228-023-03510-7 ![]() |
[118] |
Pakfetrat M, Malekmakan L, Najafi B, et al. (2023) Post-COVID-19 vaccine acute encephalitis in an adult patient: A case report and literature review. Clin Case Rep 11: e6915. https://doi.org/10.1002/ccr3.6915 ![]() |
[119] |
Wan EYF, Chui CSL, Lai FTT, et al. (2022) Bell's palsy following vaccination with mRNA (BNT162b2) and inactivated (CoronaVac) SARS-CoV-2 vaccines: a case series and nested case-control study. Lancet Infect Dis 22: 64-72. https://doi.org/10.1016/S1473-3099(21)00451-5 ![]() |
[120] |
Au SCL (2022) Facial nerve palsy: the importance of face mask and shield removal examination under the COVID-19 pandemic. Vis J Emerg Med 27: 101339. https://doi.org/10.1016/j.visj.2022.101339 ![]() |
[121] | de Araujo MR, Azenha MR, Capelari MM, et al. (2008) Management of Bell's palsy: a report of 2 cases. J Can Dent Assoc 74: 823-827. |
[122] |
Liang Z, Zhu H, Wang X, et al. (2020) Adjuvants for Coronavirus Vaccines. Front Immunol 11: 589833. https://doi.org/10.3389/fimmu.2020.589833 ![]() |
[123] |
Pollard AJ, Bijker EM (2021) A guide to vaccinology: from basic principles to new developments. Nat Rev Immunol 21: 83-100. https://doi.org/10.1038/s41577-020-00479-7 ![]() |
[124] | Sawy NA, Shahine EM, Alhadidi AS, et al. (2012) Cellular immune response in prognosis of Bell's palsy and its relation to clinical and electrophysiological findings. Alex J Med 48: 233-240. https://doi.org/10.1016/j.ajme.2012.02.006 |
[125] | Iftikhar H, Noor SMU, Masood M, et al. (2021) Bell's Palsy After 24 Hours of mRNA-1273 SARS-CoV-2 Vaccine. Cureus 13: e15935. https://doi.org/10.7759/cureus.15935 |
[126] | Shemer A, Pras E, Hecht I (2021) Peripheral Facial Nerve Palsy Following BNT162b2 (COVID-19) Vaccination. Isr Med Assoc J 23: 143-144. |
[127] |
Vojdani A, Kharrazian D (2020) Potential antigenic cross-reactivity between SARS-CoV-2 and human tissue with a possible link to an increase in autoimmune diseases. Clin Immunol 217: 108480. https://doi.org/10.1016/j.clim.2020.108480 ![]() |
[128] |
Ozonoff A, Nanishi E, Levy O (2021) Bell's palsy and SARS-CoV-2 vaccines. Lancet Infect Dis 21: 450-452. https://doi.org/10.1016/S1473-3099(21)00076-1 ![]() |
[129] | Pothiawala S (2021) Bell's Palsy After Second Dose of Moderna COVID-19 Vaccine: Coincidence or Causation?. Acta Med Litu 28: 298-301. https://doi.org/10.15388/Amed.2021.28.2.7 |
[130] |
Repajic M, Lai XL, Xu P, et al. (2021) Bell's Palsy after second dose of Pfizer COVID-19 vaccination in a patient with history of recurrent Bell's palsy. Brain Behav Immun Health 13: 100217. https://doi.org/10.1016/j.bbih.2021.100217 ![]() |
[131] |
Cirillo N, Doan R (2021) Bell's palsy and SARS-CoV-2 vaccines-an unfolding story. Lancet Infect Dis 21: 1210-1211. https://doi.org/10.1016/S1473-3099(21)00273-5 ![]() |
[132] |
Shafiq A, Salameh MA, Laswi I, et al. (2022) Neurological Immune-Related Adverse Events After COVID-19 Vaccination: A Systematic Review. J Clin Pharmacol 62: 291-303. https://doi.org/10.1002/jcph.2017 ![]() |
[133] | Nguyen TP, Taylor RS (2025) Guillain-Barre Syndrome. Treasure Island (FL): StatPearls Publishing. |
[134] |
Dimachkie MM, Barohn RJ (2013) Guillain-Barré syndrome and variants. Neurol Clin 31: 491-510. https://doi.org/10.1016/j.ncl.2013.01.005 ![]() |
[135] |
Hagen KM, Ousman SS (2021) The Neuroimmunology of Guillain-Barré Syndrome and the Potential Role of an Aging Immune System. Front Aging Neurosci 12: 613628. https://doi.org/10.3389/fnagi.2020.613628 ![]() |
[136] |
Harness J, McCombe PA (2008) Increased levels of activated T-cells and reduced levels of CD4/CD25+ cells in peripheral blood of Guillain-Barré syndrome patients compared to controls. J Clin Neurosci 15: 1031-1035. https://doi.org/10.1016/j.jocn.2007.09.016 ![]() |
[137] |
Borsellino G, Poccia F, Placido R, et al. (2000) Phenotypic and functional properties of gamma delta T cells from patients with Guillain Barré syndrome. J Neuroimmunol 102: 199-207. https://doi.org/10.1016/s0165-5728(99)00165-4 ![]() |
[138] |
Orlikowski D, Chazaud B, Plonquet A, et al. (2003) Monocyte chemoattractant protein 1 and chemokine receptor CCR2 productions in Guillain-Barré syndrome and experimental autoimmune neuritis. J Neuroimmunol 134: 118-127. https://doi.org/10.1016/s0165-5728(02)00393-4 ![]() |
[139] |
Press R, Pashenkov M, Jin JP, et al. (2003) Aberrated levels of cerebrospinal fluid chemokines in Guillain-Barré syndrome and chronic inflammatory demyelinating polyradiculoneuropathy. J Clin Immunol 23: 259-267. https://doi.org/10.1023/a:1024532715775 ![]() |
[140] |
Peng J, Zhang H, Liu P, et al. (2018) IL-23 and IL-27 Levels in Serum are Associated with the Process and the Recovery of Guillain-Barré Syndrome. Sci Rep 8: 2824. https://doi.org/10.1038/s41598-018-21025-5 ![]() |
[141] |
Pang J, Zheng Y, Han Q, et al. (2019) The Role of ALDH2 in Sepsis and the To-Be-Discovered Mechanisms. Adv Exp Med Biol 1193: 175-194. https://doi.org/10.1007/978-981-13-6260-6_10 ![]() |
[142] |
Lu MO, Zhu J (2011) The role of cytokines in Guillain-Barré syndrome. J Neuro 258: 533-548. https://doi.org/10.1007/s00415-010-5836-5 ![]() |
[143] |
Myhr KM, Vågnes KS, Marøy TH, et al. (2003) Interleukin-10 promoter polymorphisms in patients with Guillain-Barré syndrome. J Neuroimmunol 139: 81-83. https://doi.org/10.1016/s0165-5728(03)00133-4 ![]() |
[144] | Nagdev G, Chavan G, Sahu G, et al. (2022) COVID-19 Vaccination a Cause of Guillain-Barré Syndrome? A Case Series. Cureus 14: e30888. https://doi.org/10.7759/cureus.30888 |
[145] | Fernandes J, Jaggernauth S, Ramnarine V, et al. (2022) Neurological Conditions Following COVID-19 Vaccinations: Chance or Association?. Cureus 14: e21919. https://doi.org/10.7759/cureus.21919 |
[146] |
Taga A, Lauria G (2022) COVID-19 and the peripheral nervous system. A 2-year review from the pandemic to the vaccine era. J Peripher Nerv Syst 27: 4-30. https://doi.org/10.1111/jns.12482 ![]() |
[147] |
García-Grimshaw M, Michel-Chávez A, Vera-Zertuche JM, et al. (2021) Guillain-Barré syndrome is infrequent among recipients of the BNT162b2 mRNA COVID-19 vaccine. Clin Immunol 230: 108818. https://doi.org/10.1016/j.clim.2021.108818 ![]() |
[148] |
Yu M, Nie S, Qiao Y, et al. (2023) Guillain-Barre syndrome following COVID-19 vaccines: A review of literature. Front Immunol 14: 1078197. https://doi.org/10.3389/fimmu.2023.1078197 ![]() |
[149] |
Otero-Losada M, Petrovsky N, Alami A, et al. (2023) Disproportionality analysis of adverse neurological and psychiatric reactions with the ChAdOx1 (Oxford-AstraZeneca) and BNT162b2 (Pfizer-BioNTech) COVID-19 vaccines in the United Kingdom. Expert Opin Drug Saf 22: 343-349. https://doi.org/10.1080/14740338.2022.2120607 ![]() |
[150] |
Jeong J (2021) Vestibular neuritis after COVID-19 vaccination. Hum Vaccin Immunother 17: 5126-5128. https://doi.org/10.1080/21645515.2021.2013085 ![]() |
![]() |
![]() |
1. | Gi-Hun Gwon, Hyung-Jo Jung, A survey of generative models for image-based structural health monitoring in civil infrastructure, 2025, 27729915, 100138, 10.1016/j.iintel.2025.100138 | |
2. | Mohan Zhao, Yu Liu, Xinnan Xu, Yuhao Pei, Chengmiao Zhang, Chaofan Wu, Advancements in asphalt pavement recycling: Integrating falling weight impact signals for enhanced rehabilitation efficiency, 2025, 22, 22145095, e04312, 10.1016/j.cscm.2025.e04312 | |
3. | Eleni Vrochidou, George K Sidiropoulos, Athanasios G Ouzounis, Ioannis Tsimperidis, Vassilis Kalpakis, Andreas Stamkos, George A Papakostas, Utilizing generative AI for crack detection in the marble industry, 2025, 7, 2631-8695, 015236, 10.1088/2631-8695/adaca7 | |
4. | Yan Li, Zhenxing Niu, Yinzhang He, Qinshi Hu, Jiupeng Zhang, A Three-Stage Decision-Making Method Based on Machine Learning for Preventive Maintenance of Airport Pavement, 2025, 26, 1524-9050, 4152, 10.1109/TITS.2024.3514105 | |
5. | Yiyun Sun, 2025, Dugdale-GAN: Physical Dugdale Model Integrated Generative Adversarial Network for High-quality Crack Image Generation, 979-8-3315-3369-4, 286, 10.1109/ICPECA63937.2025.10928903 | |
6. | Ningyu Zhao, Yi Song, Hao Liu, Ailin Yang, Haifei Jiang, Haihong Tan, A novel MPDENet model and efficient combined loss function for real-time pixel-level segmentation detection of tunnel lining cracks, 2025, 22, 22145095, e04618, 10.1016/j.cscm.2025.e04618 | |
7. | Tianhao Ye, Min He, Yexuan Wang, Jiaying Wang, Lei Zhu, Jie Zhang, An Optimized Intelligent Segmentation Algorithm for Concrete Cracks Based on Transformer, 2025, 14, 2079-9292, 1720, 10.3390/electronics14091720 |
Dataset | CrackForest | Crack500 | CrackTree200 | GAPs384 | AEL |
Image resolution | 480 × 320 | 2000 × 1500 | 800 × 600 | 1920 × 1080 | 800 × 800 |
Amount | 96 | 1071 | 595 | 325 | 57 |
Total | 2144 |
CGAN | ACGAN | SAGAN | ||||
Type of cracks | Longitudinal Crack | Transverse Crack | Longitudinal Crack | Transverse Crack | Longitudinal Crack | Transverse Crack |
IS | 1.44 ±0.03 | 1.33 ±0.06 | 1.61 ±0.04 | 1.46 ±0.05 | 1.73 ±0.05 | 1.59 ±0.07 |
FID | 133.76 | 124.06 | 81.15 | 73.73 | 71.29 | 68.01 |
Dataset | CrackForest | Crack500 | CrackTree200 | GAPs384 | AEL |
Image resolution | 480 × 320 | 2000 × 1500 | 800 × 600 | 1920 × 1080 | 800 × 800 |
Amount | 96 | 1071 | 595 | 325 | 57 |
Total | 2144 |
CGAN | ACGAN | SAGAN | ||||
Type of cracks | Longitudinal Crack | Transverse Crack | Longitudinal Crack | Transverse Crack | Longitudinal Crack | Transverse Crack |
IS | 1.44 ±0.03 | 1.33 ±0.06 | 1.61 ±0.04 | 1.46 ±0.05 | 1.73 ±0.05 | 1.59 ±0.07 |
FID | 133.76 | 124.06 | 81.15 | 73.73 | 71.29 | 68.01 |